Search results for "succinate"

showing 10 items of 105 documents

Arginine Depletion in Combination with Canavanine Supplementation Induces Massive Cell Death in Myeloma Cells By Interfering with Their Protein Metab…

2018

Abstract Introduction Although the therapeutic armamentarium against multiple myeloma has tremendously increased in recent years, it still remains an incurable disease. A highly promising novel anti-tumoral treatment strategy is to target specific non-redundant metabolic achilles heels of individual cancer entities. The semi-essential amino acid arginine can be synthesized from citrulline in most physiological tissues due to expression of the rate-limiting enzyme argininosuccinate synthetase 1 (ASS1). Various tumor entities do not express ASS1, therefore depend on the exogenous availability of arginine and pharmacological approaches to systemically deplete arginine are in phase I-III clinic…

Programmed cell deathArgininebiologyBortezomibChemistryImmunologyArgininosuccinate synthaseCaspase 3Cell BiologyHematologyBiochemistryCell biologychemistry.chemical_compoundCell culturemedicinebiology.proteinCitrullineCanavaninemedicine.drugBlood
researchProduct

Fluid resuscitation-related coagulation impairment in a porcine hemorrhagic shock model.

2020

Background Fast and effective treatment of hemorrhagic shock is one of the most important preclinical trauma care tasks e.g., in combat casualties in avoiding severe end-organ damage or death. In scenarios without immediate availability of blood products, alternate regimens of fluid resuscitation represent the only possibility of maintaining sufficient circulation and regaining adequate end-organ oxygen supply. However, the fluid choice alone may affect the extent of the bleeding by interfering with coagulation pathways. This study investigates the impact of hydroxyethyl starch (HES), gelatine-polysuccinate (GP) and balanced electrolyte solution (BES) as commonly used agents for fluid resu…

ResuscitationEmergency and Critical CareHydroxyethyl starchSurgery and Surgical SpecialtiesCardiologylcsh:MedicineHemodynamicsHydroxyethyl starchGeneral Biochemistry Genetics and Molecular BiologyMicrocirculation03 medical and health sciences0302 clinical medicine030202 anesthesiologymedicineCoagulation (water treatment)Gelatine-polysuccinateAnesthesiology and Pain ManagementROTEMbusiness.industryGeneral NeuroscienceFluid resuscitationlcsh:RThromboelastometry030208 emergency & critical care medicineHESGeneral MedicineHematologyPig modelThromboelastometryBloodAnesthesiaHemorrhagic shockArterial bloodHemoglobinGeneral Agricultural and Biological Sciencesbusinessmedicine.drugPeerJ
researchProduct

Partial purification and characterization of succinyl-CoA synthetase from Saccharomyces cerevisiae

1983

Succinyl-CoA synthetase from Saccharomyces cerevisiae was partially purified (20-fold) with a yield of 44%. The Michaelis-Menten constants were determined: Km (succinate) = 17 mM; Km (ATP) = 0.13 mM; Km (CoA) = 0.03 mM. The succinyl-CoA synthetase has a molecular weight of about 80000 dalton (as determined by polyacrylamide gradient gel electrophoresis). The pH optimum is at 6.0. During fermentation the activity of succinyl-CoA synthetase is lower than in aerobically grown yeast cells. The presence of succinyl-CoA synthetase in fermenting yeasts may be regarded as an indication for the oxidative formation of succinate. In fermenting yeast cells succinyl-CoA synthetase is repressed by glucos…

Saccharomyces cerevisiaeSuccinic AcidCatabolite repressionSaccharomyces cerevisiaeMicrobiologyAdenosine TriphosphateCoenzyme A LigasesSuccinate-CoA LigasesAnaerobiosisMolecular BiologyGel electrophoresischemistry.chemical_classificationChromatographybiologyorganic chemicalsSuccinyl coenzyme A synthetaseTemperatureSuccinatesSuccinate-CoA LigasesGeneral MedicineHydrogen-Ion Concentrationbiology.organism_classificationYeastAmino acidMolecular WeightKineticsBiochemistrychemistrybacteriaFermentationAntonie van Leeuwenhoek
researchProduct

Polybutylene succinate artificial scaffold for peripheral nerve regeneration

2021

Regeneration and recovery of nerve tissues are a great challenge for medicine, and positively affect the quality of life of patients. The development of tissue engineering offers a new approach to the problem with the creation of multifunctional artificial scaffolds that act on various levels in the damaged tissue, providing physical and biochemical support for the growth of nerve cells. In this study, the effects of the use of a tubular scaffold made of polybutylene succinate (PBS), surgically positioned at the level of a sciatic nerve injured in rat, between the proximal stump and the distal one, was investigated. Scaffolds characterization was carried out by scanning electron microscopy …

ScaffoldMaterials sciencePolymersBiomedical EngineeringContext (language use)02 engineering and technologyRats Sprague-DawleyBiomaterials03 medical and health sciencesTissue engineeringIn vivoElectroneuronographyAnimalsHumansButylene Glycols030304 developmental biology0303 health sciencesTissue ScaffoldsbiologyRegeneration (biology)X-Ray Microtomography021001 nanoscience & nanotechnologySciatic Nervenerve regeneration electrospinning poly(14-butylene succinate) (PBS) artificial conduits sciatic nerveNerve RegenerationRatsQuality of Lifebiology.proteinSciatic nerve0210 nano-technologyBiomedical engineeringNeurotrophinJournal of Biomedical Materials Research Part B: Applied Biomaterials
researchProduct

Escherichia coli possesses two homologous anaerobic C4-dicarboxylate membrane transporters (DcuA and DcuB) distinct from the aerobic dicarboxylate tr…

1994

The nucleotide sequences of two Escherichia coli genes, dcuA and dcuB (formerly designated genA and genF), have been shown to encode highly homologous products, M(r) 45,751 and 47,935 (434 and 446 amino acid residues) with 36% sequence identity (63% similarity). These proteins have a high proportion (approximately 61%) of hydrophobic residues and are probably members of a new group of integral inner membrane proteins. The locations of the dcu genes, one upstream of the aspartase gene (dcuA-aspA) and the other downstream of the anaerobic fumarase gene (fumB-dcuB), suggested that they may function in the anaerobic transport of C4-dicarboxylic acids. Growth tests and transport studies with mut…

Sequence analysisMolecular Sequence DataMutantSuccinic AcidBiologymedicine.disease_causeMicrobiologyProtein Structure SecondarySubstrate SpecificityProtein structureBacterial ProteinsFumaratesEscherichia colimedicineAmino Acid SequenceAnaerobiosisMolecular BiologyGeneEscherichia coliPeptide sequenceDicarboxylic Acid Transporterschemistry.chemical_classificationAspartic AcidBase SequenceSequence Homology Amino AcidEscherichia coli ProteinsMembrane ProteinsBiological TransportSuccinatesSequence Analysis DNAAerobiosisAmino acidRepressor ProteinschemistryBiochemistryMembrane proteinGenes BacterialCarrier ProteinsResearch ArticleTranscription FactorsJournal of Bacteriology
researchProduct

Combination strategies for enhancing transdermal absorption of sumatriptan through skin

2006

The aim of the present work was to characterize in vitro sumatriptan transdermal absorption through human skin and to investigate the effect of chemical enhancers and iontophoresis applied both individually and in combination. A secondary objective was to compare the results obtained with those in porcine skin under the same conditions, in order to characterize the relationship between the two skin models and validate the porcine model for further research use. Transdermal flux of sumatriptan was determined in different situations: (a) after pre-treatment of human skin with ethanol, Azone (1-dodecyl-azacycloheptan-2-one), polyethylene glycol 600 and R-(+)-limonene, (b) under iontophoresis a…

Skin AbsorptionSus scrofaPharmaceutical ScienceHuman skinPolyethylene glycolAbsorption (skin)In Vitro TechniquesPharmacologyAdministration CutaneousPolyethylene Glycolschemistry.chemical_compoundSumatriptan SuccinateCyclohexenesmedicineAnimalsHumansAdjuvants PharmaceuticSkinTransdermalEthanolintegumentary systemIontophoresisSumatriptanTerpenesAzepinesIontophoresisSerotonin Receptor AgonistsSumatriptanchemistryLimoneneAzoneBiomedical engineeringmedicine.drugInternational Journal of Pharmaceutics
researchProduct

On-line sample treatment and FT-IR determination of doxylamine succinate in pharmaceuticals

2005

Abstract A low solvent consumption method for Fourier transform infrared spectroscopy (FT-IR) determination of doxylamine succinate in pharmaceuticals has been developed. The analyte was continuous and selectively extracted with a 13% (v/v) ethanol:chloroform solvent mixture, recirculating the solvent through the sample and monitoring the process by FT-IR. Doxylamine succinate was determined by on-line standard addition measuring the peak area in the regions 1730–1710 and 1485–1462 cm −1 corrected with a two-point baseline established between 2000 and 1800 cm −1 . This new method implies low volumes of chloroformic solvent mixture, only 2.6 mL per sample, in front of classical batch FT-IR m…

SolventAnalyteChromatographyDoxylamineChemistryStandard additionmedicineSample preparationDoxylamine SuccinateFourier transform infrared spectroscopyFourier transform spectroscopyAnalytical Chemistrymedicine.drugTalanta
researchProduct

CCDC 910562: Experimental Crystal Structure Determination

2013

Related Article: Nonappa,M.Lahtinen,E.Kolehmainen,J.Haarala,A.Shevchenko|2013|Cryst.Growth Des.|13|346|doi:10.1021/cg3015282

Space GroupCrystallographyCrystal System2-sec-Butyl-4-(4-(4-(4-((2-(24-dichlorophenyl)-2-(1H-124-triazol-1-ylmethyl)-13-dioxolan-4-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-24-dihydro-3H-124-triazol-3-one succinateCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 777361: Experimental Crystal Structure Determination

2012

Related Article: S.Ikonen, O.Jurcek, Z.Wimmer, P.Drasar, E.Kolehmainen|2012|J.Mol.Struct.|1011|25|doi:10.1016/j.molstruc.2011.12.016

Space GroupCrystallographyCrystal SystemCholest-5-en-3-yl 26-di-t-butyl-4-((2-((35-di-t-butyl-4-hydroxyphenyl)sulfanyl)propan-2-yl)sulfanyl)phenyl succinateCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 777362: Experimental Crystal Structure Determination

2012

Related Article: S.Ikonen, O.Jurcek, Z.Wimmer, P.Drasar, E.Kolehmainen|2012|J.Mol.Struct.|1011|25|doi:10.1016/j.molstruc.2011.12.016

Space GroupCrystallographyCrystal SystemCrystal StructureCell Parameters26-Di-t-butyl-4-((2-((35-di-t-butyl-4-hydroxyphenyl)sulfanyl)propan-2-yl)sulfanyl)phenyl stigmast-5-en-3-yl succinateExperimental 3D Coordinates
researchProduct